MAPK3 and ischemic stroke: On the basis of the KEGG enrichment analysis of network pharmacology, the MAPK signaling pathway was one of the main signaling pathways of RPR in treating ischemic stroke, and the PPI network displayed the main target as MAPK3 (ERK 1) and MAPK14 (p38).